Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

Breast. 2015 Jun;24(3):290-3. doi: 10.1016/j.breast.2015.01.009. Epub 2015 Feb 18.

Abstract

Background: Tumour infiltrating lymphocytes (TILs) is one of the most exciting breast cancer biomarkers, yet no data is available on its prevalence in tumours diagnosed during pregnancy.

Methods: We evaluated the prevalence of TILs (stromal and intratumoural) in pregnant and non-pregnant young breast cancer patients.

Results: 11/116 (9.6%) of the non-pregnant and 2/86 (2.3%) pregnant patients had TILs ≥ 50% (p < 0.001) with highest prevalence observed in triple negative tumours (p = 0.01).

Conclusions: This is the first report on TILs in tumours diagnosed during pregnancy. The low prevalence could reflect the state of low host immunity associated with pregnancy.

Keywords: Biology; Breast cancer during pregnancy; Tumour infiltrating lymphocytes; Young.

MeSH terms

  • Adult
  • Breast Neoplasms / immunology*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Immunity, Cellular*
  • Lymphocytes, Tumor-Infiltrating / cytology*
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Neoplastic / immunology*
  • Pregnancy Complications, Neoplastic / pathology
  • Young Adult